Egrifta (eh-GRIF-tuh, tesamorelin), the first drug to treat abdominal fat deposits caused by HIV meds

You'll hear about Egrifta (eh-GRIF-tuh, tesamorelin), the first drug to treat abdominal fat deposits caused by HIV meds.

This lipodystrophy can be distressing to patients...decrease adherence to HIV meds...and might increase cardiovascular risk.

Egrifta is a human growth hormone releasing factor that's injected subcutaneously once daily.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote